"We hope more hear about us now, so even more patients can get faster care," Erik Rask said, emphasizing the potential impact of increased visibility post-investment.
In 2023, Medbeat had € 500.000 in revenue with sales growing in 2024. Erik highlights their quick sales processes, contributing to faster growth compared to other medtech companies.
The appearance on SVT's Draknästet generated significant interest, with many healthcare facilities reaching out afterwards, indicating a strong demand for their innovative monitoring solutions.
Medbeat secured € 135.000 from three investors on SVT's Draknästet, valuing the company at over € 7 million, and plans to expand its market presence.
Collection
[
|
...
]